Generali is looking for startups in the eHealth sector that will allow the company to offer new solutions, products and services to the market. On the one hand, Generali aims to find innovative and disruptive solutions in the field of telemedicine, as well as to design new business models. Within this framework, the Company seeks new ways to interact with its customers in a personalized way, and especially to promote contact with customers living in geographical areas with lower population density. On the other hand, Generali wants to extend its offer to new customers and market segments through innovative and differential products, as well as through prevention and value-added services. Generali is a company open to innovation. In its Group strategy 2019-2021, "innovation and digital transformation" is established as one of the three main…
OpenZone Accelerator's 2020 Call for Solutions, mainly focused on the therapeutic areas of the Central Nervous System and the Respiratory, is looking for innovative projects in 4 macro technological areas plus a unique challenge: Digital Prevention, monitoring, and therapeutics Digital Diagnostics Virtual Health Clinical Trials Digitalization The 2020 Call for Solutions opened on May 18 and will be running until July 20. The 4-week acceleration journey, whose estimated value is around € 25,000, consists of personalized online sessions and on-site sessions that will take place in OpenZone. Finally, upon completion of the acceleration program, the best projects can receive a milestone-based seed investment up to €100,000. Open Accelerator is the international acceleration program dedicated to startups operating in the Life Science field. Created in 2016 and sponsored by ZCube, Zambon…
The G4A Growth and Advance Tracks offer a gateway to partner with Bayer through integrated healthcare solutions in the digital health space. Our partners benefit from our global presence and business acumen to grow their healthcare business while we drive towards changing the experience of health through collaboration. Applications are now open till June 30th, 11:59 CET. GROWTH TRACK This track is designed for companies in the early-mid stage (Pre-seed- Series A). Ideal candidates are seed-Series A startups with a Minimal Viable Product validated through patents and publications. And of course, a stellar and diverse team! Startup companies will be offered EUR 75,000 in a convertible loan. In addition to healthcare technology funding, we provide a dedicated workspace (Berlin, DE) and mentorship from industry experts. ADVANCE TRACK The Advance Track…
TecnoCampus, with the support of ACCIÓ, is launching TecnoCampus StartHealth, an acceleration program for projects with high growth potential in the health sector. The program offers assistance in the validation of the technology and the business model in the launch of the product in the market and the access to financing to accelerate its growth. Deadline: June 15, 2020 Five-month and 25-hour mentoring acceleration program focused on projects with high growth potential in the health sector: D-Health, Medical Devices, and Biotech. We help you define and validate your business model, launch your product in the market, and access financing, with the support of professionals and mentors experts in the sector. Workspace in the coworking of the TecnoCampus Incubator. Free program with limited places. If you need expert advice to launch your startup with…
Banco Sabadell, through the investment program BStartup10, opens its call for entries for the 3rd Edition of BStartup Health to support projects in the health sector in pre-seed and seed stages. At a time when the importance of science and research is becoming extremely apparent, this edition’s investment is aimed at validating technology/research and business; therefore, three projects will be selected from all those submitted in Spain. The 3rd Edition of BStartup Health has a Scientific-Technical Committee made up by investors and entrepreneurs who are experts in health: Clara Campàs: Founding Partner at Asabys Partners, former Strategy & Development Director at Kern Pharma, CEO at Advancell and VP at CataloniaBIO&Healthtech. Ph.D. from the University of Barcelona. Carlos Gallardo: Founder at CG Health Partners, Board Member at Almirall, Ex-Managing Director UK at Almirall and Ex-Venture Partner at Ysios Capital. Damià…
DKV Impacta - an initiative of social innovation in health which we aim to go beyond the financing of projects since we offer to the professionals of the social organizations and entrepreneurs accompanying, mentoring and training in business model and strategy through the use of various innovation methodologies. Who can apply? Foundations, associations and social entrepreneurship initiatives. Deadline: May 10, 2020 DKV renova la seva clàssica Convocatòria d'Ajudes i Subvencions per a entitats socials llançant una nova iniciativa: DKV Impacta és una iniciativa d'innovació social en salut amb la qual pretenem anar més enllà del finançament de projectes, ja que oferim als professionals de les entitats socials i als emprenedors acompanyament, mentoria i formació en estratègia i model de negoci mitjançant l'ús de diverses metodologies d'innovació. Fundacions, associacions i iniciatives d'emprenedoria social. Què…
BIH Digital Health Accelerator - If you are affiliated with Charité or MDC and have an idea for a new digital health solution, apply to become part of our next BIH Digital Health Accelerator cohort! Benefit from expert mentoring, protected time off, flexible funding, free co-working space, and high-quality connections to the industry. Deadline: May 5, 2020 Ambitious? Want to bring your digital health solution to patients? Benefit from our resources, expertise, and network which will support you in all aspects of building, validating, and launching your digital health solutions. Why should I apply? Our mission at the Digital Health Accelerator is to lay the groundwork for great ideas to grow, therefore we are committed to providing program participants with optimal working conditions ranging from solid funding to diverse external support. Flexible Funding: We offer…
Lab4pymes, the program of the Carlos III University of Madrid (UC3M), for small and medium-sized companies (SMEs) that have their registered office and work center located in the Community of Madrid. An active 6-month innovation program, in which UC3M makes eleven technologies available to SMEs in four areas of knowledge with the aim of helping to drive innovation and business competitiveness. The objective is to help them in the development of new products and services based on technological assets and knowledge of the University. Deadline: Apr 27, 2020 Lab4pymes - Ventajas Primera edición de un programa de innovación de 6 meses activos, en el que la UC3M pone a disposición de las PYMES once tecnologías en cuatro áreas de conocimiento con el objetivo de ayudar a impulsar la innovación y…
The Innovative Medicines Initiative (IMI) is a public-private partnership aiming to speed up the development of medicines. IMI2 - Call 20 - Cancer, tuberculosis and vaccines in new IMI Call for proposals with a total budget of EUR 273 million. Deadline: Apr 21, 2020 Call-ID: H2020-JTI-IMI2-2020-20-two-stage Action Type: RIA – Research and Innovation Actions Topics Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis Topic 2: Innovations to accelerate vaccine development and manufacture Topic 3: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB) This topic is part of the IMI AMR Accelerator Programme. Applicants should also read the Questions and Answers on the programme (document last updated November 2019). Topic 4: Tumour plasticity Topic 5: Proton versus photon therapy for oesophageal cancer –…
IMAGINE IF! - an acceleration program built by Innovation Forum. IMAGINE IF! provides early-stage science startups with extensive opportunities: mentorship, the potential to secure non-dilutive capital, free advice from leading professional service companies and rapid networking across the Innovation Forum’s platform. Barcelona, Spain; Deadline: Apr 15, 2020 IMAGINE IF! is a leading global competition and pre-acceleration program for science-based ventures. Why apply? The IMAGINE IF! offers: Non–dilutive cash prize FREE 6 months of laboratory space Mentoring by industry professionals from leading corporations including Johnson & Johnson, AstraZeneca, and others Access to an international network FREE ticket to pitch at the Global Investor Conference at the IMAGINE IF! Finals (for the Top 15 startups) Local winners will have the guaranteed opportunity to pitch in the global final at the annual conference, where they compete to win a non-dilutive cash prize. As…
